Accelerating Research & Development for Advanced Therapies (ARDAT) Overview
- Website
- ardat.org
- Industry
- Biotechnology Research
- Employees
- 126
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Accelerating Research & Development for Advanced Therapies (ARDAT)
The ARDAT consortium – “Accelerating Research and Development for Advanced Therapies” is a collaboration between academic institutions (Universities and Research Centres), small and medium-sized businesses, and European Federation of Pharmaceutical Industries and Association (EFPIA) members, which is due to run until November 2025 and is funded by the Innovative Medicines Initiative (IMI).
Compare Similar Companies to Accelerating Research & Development for Advanced Therapies (ARDAT)
ASPHALION
Pharmaceutical Manufacturing
Carrigent
Biotechnology Research
Innovation Hub for Gene Therapies: London (GTVF)
Manufacturing
Native Labs
Biotechnology Research
COAST CONNECT INTERNATIONAL HOLDINGS
Pharmaceutical Manufacturing
Pinnacle Biopartners
Strategic Management Services
Aspire BioScience
Pharmaceutical Manufacturing
Innovation Hubs for Gene Therapies
Manufacturing
EUROPEAN GENERIC MEDICINES ASSOCIATION
Related company record
PEPR Biothérapies et Bioproduction de Thérapies Innovantes
Research Services